Literature DB >> 18506897

Coordinate regulation of gallbladder motor function in the gut-liver axis.

Piero Portincasa1, Agostino Di Ciaula, Helen H Wang, Giuseppe Palasciano, Karel J van Erpecum, Antonio Moschetta, David Q-H Wang.   

Abstract

Gallstones are one of the most common digestive diseases with an estimated prevalence of 10%-15% in adults living in the western world, where cholesterol-enriched gallstones represent 75%-80% of all gallstones. In cholesterol gallstone disease, the gallbladder becomes the target organ of a complex metabolic disease. Indeed, a fine coordinated hepatobiliary and gastrointestinal function, including gallbladder motility in the fasting and postprandial state, is of crucial importance to prevent crystallization and precipitation of excess cholesterol in gallbladder bile. Also, gallbladder itself plays a physiopathological role in biliary lipid absorption. Here, we present a comprehensive view on the regulation of gallbladder motor function by focusing on recent discoveries in animal and human studies, and we discuss the role of the gallbladder in the pathogenesis of gallstone formation.

Entities:  

Mesh:

Year:  2008        PMID: 18506897     DOI: 10.1002/hep.22204

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

1.  The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2016-01-12       Impact factor: 4.686

Review 2.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

Review 3.  Cholecystectomy and risk of metabolic syndrome.

Authors:  Agostino Di Ciaula; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Eur J Intern Med       Date:  2018-04-26       Impact factor: 4.487

4.  Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice.

Authors:  Ornella de Bari; Tony Y Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  J Lipid Res       Date:  2015-07-07       Impact factor: 5.922

Review 5.  Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease.

Authors:  Helen H Wang; Min Liu; Xiaodan Li; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2017-03-08       Impact factor: 4.686

6.  Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies.

Authors:  Dominique Debray; Dominique Rainteau; Véronique Barbu; Myriam Rouahi; Haquima El Mourabit; Stéphanie Lerondel; Colette Rey; Lydie Humbert; Dominique Wendum; Charles-Henry Cottart; Paul Dawson; Nicolas Chignard; Chantal Housset
Journal:  Gastroenterology       Date:  2012-02-24       Impact factor: 22.682

Review 7.  Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

8.  Embryonic cholecystitis and defective gallbladder contraction in the Sox17-haploinsufficient mouse model of biliary atresia.

Authors:  Hiroki Higashiyama; Aisa Ozawa; Hiroyuki Sumitomo; Mami Uemura; Ko Fujino; Hitomi Igarashi; Kenya Imaimatsu; Naoki Tsunekawa; Yoshikazu Hirate; Masamichi Kurohmaru; Yukio Saijoh; Masami Kanai-Azuma; Yoshiakira Kanai
Journal:  Development       Date:  2017-04-21       Impact factor: 6.868

9.  Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice.

Authors:  Helen H Wang; Piero Portincasa; Min Liu; Patrick Tso; Linda C Samuelson; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2009-10-22

10.  Endogenous elevation of plasma cholecystokinin does not prevent gallstones.

Authors:  Rafiq A Shahid; David Q-H Wang; Brian E Fee; Shannon J McCall; Joelle M-J Romac; Steven R Vigna; Rodger A Liddle
Journal:  Eur J Clin Invest       Date:  2015-03       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.